Stay updated on Pyrotinib Combo in HR+/HER2- Clinical Trial
Sign up to get notified when there's something new on the Pyrotinib Combo in HR+/HER2- Clinical Trial page.

Latest updates to the Pyrotinib Combo in HR+/HER2- Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedAdded a recruitment status note 'No longer looking for participants' and updated the record to revision 'v3.6.0', while removing the previous revision 'v3.5.5' from the history.SummaryDifference0.4%

- Check16 days agoChange DetectedA new revision entry v3.5.5 has been added to the page history. The previous revision v3.5.4 has been removed.SummaryDifference0.1%

- Check38 days agoChange DetectedThe page now shows Revision: v3.5.4, replacing v3.5.3, indicating a new site release. The change affects only the version label and does not modify the study details or displayed information.SummaryDifference0.1%

- Check59 days agoChange DetectedThe page’s footer revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a general platform release rather than modifications to the clinical trial record content.SummaryDifference0.1%

- Check66 days agoChange DetectedAdded Revision: v3.5.2 to the record history and removed Revision: v3.5.0.SummaryDifference0.1%

- Check95 days agoChange DetectedRevision v3.5.0 was added and revision v3.4.3 was deleted from the Study Record Versions.SummaryDifference0.1%

Stay in the know with updates to Pyrotinib Combo in HR+/HER2- Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pyrotinib Combo in HR+/HER2- Clinical Trial page.